BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17381514)

  • 1. Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein.
    Tsigelny IF; Bar-On P; Sharikov Y; Crews L; Hashimoto M; Miller MA; Keller SH; Platoshyn O; Yuan JX; Masliah E
    FEBS J; 2007 Apr; 274(7):1862-77. PubMed ID: 17381514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    Tsigelny IF; Crews L; Desplats P; Shaked GM; Sharikov Y; Mizuno H; Spencer B; Rockenstein E; Trejo M; Platoshyn O; Yuan JX; Masliah E
    PLoS One; 2008 Sep; 3(9):e3135. PubMed ID: 18769546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
    Illes-Toth E; Ramos MR; Cappai R; Dalton C; Smith DP
    Biochem J; 2015 Jun; 468(3):485-93. PubMed ID: 25851527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins.
    Jain MK; Singh P; Roy S; Bhat R
    Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.
    O'Leary EI; Jiang Z; Strub MP; Lee JC
    J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation.
    Tsigelny IF; Sharikov Y; Wrasidlo W; Gonzalez T; Desplats PA; Crews L; Spencer B; Masliah E
    FEBS J; 2012 Mar; 279(6):1000-13. PubMed ID: 22251432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of α- and β-synuclein regulate cellular susceptibility to toxicity from α-synuclein oligomers.
    Angelova DM; Jones HBL; Brown DR
    FASEB J; 2018 Feb; 32(2):995-1006. PubMed ID: 29054856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different species of alpha-synuclein oligomers induce calcium influx and seeding.
    Danzer KM; Haasen D; Karow AR; Moussaud S; Habeck M; Giese A; Kretzschmar H; Hengerer B; Kostka M
    J Neurosci; 2007 Aug; 27(34):9220-32. PubMed ID: 17715357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method.
    Tsukakoshi K; Abe K; Sode K; Ikebukuro K
    Anal Chem; 2012 Jul; 84(13):5542-7. PubMed ID: 22697251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation.
    Chai YJ; Sierecki E; Tomatis VM; Gormal RS; Giles N; Morrow IC; Xia D; Götz J; Parton RG; Collins BM; Gambin Y; Meunier FA
    J Cell Biol; 2016 Sep; 214(6):705-18. PubMed ID: 27597756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.
    Brown JW; Buell AK; Michaels TC; Meisl G; Carozza J; Flagmeier P; Vendruscolo M; Knowles TP; Dobson CM; Galvagnion C
    Sci Rep; 2016 Nov; 6():36010. PubMed ID: 27808107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication.
    Xie YY; Zhou CJ; Zhou ZR; Hong J; Che MX; Fu QS; Song AX; Lin DH; Hu HY
    FASEB J; 2010 Jan; 24(1):196-205. PubMed ID: 19762560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the intrinsically unfolded protein beta-synuclein, a natural negative regulator of alpha-synuclein aggregation.
    Bertoncini CW; Rasia RM; Lamberto GR; Binolfi A; Zweckstetter M; Griesinger C; Fernandez CO
    J Mol Biol; 2007 Sep; 372(3):708-22. PubMed ID: 17681539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
    Palazzi L; Leri M; Cesaro S; Stefani M; Bucciantini M; Polverino de Laureto P
    Biochem Pharmacol; 2020 Mar; 173():113722. PubMed ID: 31756328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail.
    Tamamizu-Kato S; Kosaraju MG; Kato H; Raussens V; Ruysschaert JM; Narayanaswami V
    Biochemistry; 2006 Sep; 45(36):10947-56. PubMed ID: 16953580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
    Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
    Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.